Ono Pharmaceutical Co., Ltd.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
9/10
|
9.37 | 117.69 | -92.04% | 8.14 | +15.06% |
| P/S |
|
2.38 | 8.16 | -70.78% |
|
|
| P/BV |
|
1.5 | 3.37 | -55.46% |
|
|
| P/FCF |
|
0.1034 | 160.84 | -99.94% |
|
|
| Ev/Ebitda |
|
5.75 | 52.39 | -89.03% |
|
|
| Ev/S |
|
2.07 | 6.96 | -70.24% |
|
|
| Ev/FCF |
|
11.59 | 142.77 | -91.88% |
|
|
| E/P |
|
13.78 | 1.47 | 838.9% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
9/10
|
36.06 | 24.93 | 44.6% | 35.33 | +2.05% |
| ROE |
|
16.14 | 12.96 | 24.52% |
|
|
| ROA |
|
14.01 | 6.09 | 129.91% |
|
|
| ROIC |
|
19.96 | 15.56 | 28.28% |
|
|
| ROS |
|
25.46 | 12.55 | 102.85% |
|
|
| ROCE |
|
20.42 | 16.88 | 20.97% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
0.0489 | 143.57 | -99.97% | 0.0685 | -28.61% |
| Nеt Debt/Ebitda |
|
-0.8678 | -5.05 | -82.83% |
|
|
| Debt/Ratio |
|
0.0097 | 0.4053 | -97.61% |
|
|
| Debt/Equity |
|
0.0967 | 11.8 | -99.18% |
|
|
| Debt/Net Income |
|
0.0692 | 147.58 | -99.95% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 1.73 | -100% | 2.55 | -100% |
| Number of years of dividend growth |
|
1 | 1.07 | -6.58% | ||
| DSI |
|
0.7857 | 0.7807 | 0.6379% |
|
|
| Average dividend growth |
|
5.41 | -79.6 | -106.8% |
|
|
| Average percentage for 5 years |
|
2.55 | 2.81 | -9.44% |
|
|
| Average percentage for payments |
|
56.73 | 247.07 | -77.04% |
|
|
| Difference from average difference in sector |
|
-1.73 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
8/10
|
71.9 | 180.62 | -60.19% | ||
| Growth impulse Ebitda in 5 years |
|
91.27 | 201.95 | -54.81% | ||
| Growth impulse Net Income in 5 years |
|
114.35 | 160.03 | -28.54% | ||
| Growth impulse FCF in 5 years |
|
73.71 | 118.65 | -37.88% | ||
| Growth impulse EPS in 5 years |
|
-25.04 | 280.49 | -108.93% |
IP Score
7.37/10
